Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer
View/ Open
Use this link to cite
http://hdl.handle.net/2183/21886Collections
- INIBIC-OCT - Artigos [21]
Metadata
Show full item recordTitle
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancerAuthor(s)
Date
2014-06-20Citation
Blanco-Calvo M, Tarrío N, Reboredo M, et al. Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer. Future Oncol. 2014; 10(7): 1187-1202
Abstract
[Abstract] Aim: To analyze GDF15 and MMP7 serum levels as diagnostic biomarkers in gastric cancer (GC) patients. The prognostic value of GDF15 and MMP7 serum levels in combination with miR-200c blood expression was also analyzed. Patients & methods: Fifty-two GC and 23 control samples were included. Results: GDF15 and MMP7 proved to be powerful tools for GC diagnosis. Increased levels of GDF15 and MMP7 were associated with shorter progression-free survival and overall survival in univariate analysis. In multivariate analysis, the combination of high levels of GDF15, MMP7 and miR-200c was an independent predictor for death (p = 0.033). Conclusion: GDF15 and MMP7 serum levels have diagnostic value for GC. The combination marker formed by GDF15, MMP7 and miR-200c is indicative of adverse evolution in GC patients.
Keywords
Biomarker
Diagnostic
Gastric cancer
GDF15
Metastasis
miR-200c
MMP7
Prognostic
Diagnostic
Gastric cancer
GDF15
Metastasis
miR-200c
MMP7
Prognostic
Editor version
ISSN
1479-6694